Detection of Epstein‒Barr virus DNA methylation as tumor markers of nasopharyngeal carcinoma patients in saliva, oropharyngeal swab, oral swab, and mouthwash
- PMID: 39161799
- PMCID: PMC11331033
- DOI: 10.1002/mco2.673
Detection of Epstein‒Barr virus DNA methylation as tumor markers of nasopharyngeal carcinoma patients in saliva, oropharyngeal swab, oral swab, and mouthwash
Abstract
Saliva biopsy of nasopharyngeal carcinoma (NPC) has been developed in our latest study, indicating the application of oral sampling in NPC detection. Further exploration of the potential for self-sampling from the oral cavity is necessary. A total of 907 various samples from oral cavity, including saliva (n = 262), oropharyngeal swabs (n = 250), oral swabs (n = 210), and mouthwash (n = 185), were collected. Epstein‒Barr virus (EBV) DNA methylation at the 12,420 bp CpG site in EBV genome from the repeat-copy W promoter (Wp) region and at the 11,029 bp CpG site in the single-copy C promoter (Cp) region were simultaneously detected in these samples. A significant increase in EBV methylation, no matter at Wp or Cp region, was found in all types of samples from NPC patients. However, EBV DNA methylation in saliva and oropharyngeal swab showed a better diagnostic performance in detecting NPC. The combination of these two sample types and two markers could help to improve the detection of NPC. Our study further explored the optimal self-sampling methods and detection target in the detection of NPC and may facilitate the application of EBV DNA methylation detection in a home-based large-scale screening of NPC.
Keywords: Epstein‒Barr virus DNA methylation; nasopharyngeal carcinoma; oral swab; oropharyngeal swab; saliva.
© 2024 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.
Conflict of interest statement
The authors declare they have no conflicts of interest.
Figures


Similar articles
-
Quantitative detection of Epstein-Barr virus DNA methylation in the diagnosis of nasopharyngeal carcinoma by blind brush sampling.Int J Cancer. 2023 Jun 15;152(12):2629-2638. doi: 10.1002/ijc.34491. Epub 2023 Mar 13. Int J Cancer. 2023. PMID: 36878711
-
Detection of methylation status of Epstein-Barr virus DNA C promoter in the diagnosis of nasopharyngeal carcinoma.Cancer Sci. 2020 Feb;111(2):592-600. doi: 10.1111/cas.14281. Epub 2020 Feb 5. Cancer Sci. 2020. PMID: 31834989 Free PMC article.
-
Development and analytical validation of a novel nasopharynx swab-based Epstein-Barr virus C promoter methylation quantitative assay for nasopharyngeal carcinoma detection.Clin Chem Lab Med. 2023 Aug 4;62(1):187-198. doi: 10.1515/cclm-2023-0510. Print 2024 Jan 26. Clin Chem Lab Med. 2023. PMID: 37531579
-
Recent Advances in Assessing the Clinical Implications of Epstein-Barr Virus Infection and Their Application to the Diagnosis and Treatment of Nasopharyngeal Carcinoma.Microorganisms. 2023 Dec 20;12(1):14. doi: 10.3390/microorganisms12010014. Microorganisms. 2023. PMID: 38276183 Free PMC article. Review.
-
Clinical utility of Epstein-Barr virus DNA and other liquid biopsy markers in nasopharyngeal carcinoma.Cancer Commun (Lond). 2020 Nov;40(11):564-585. doi: 10.1002/cac2.12100. Epub 2020 Sep 28. Cancer Commun (Lond). 2020. PMID: 32989921 Free PMC article. Review.
Cited by
-
Oncoviruses in the Oral Cavity: Recent Advances in Understanding Viral Infections and Tumorigenesis.Int J Mol Sci. 2025 Jul 13;26(14):6721. doi: 10.3390/ijms26146721. Int J Mol Sci. 2025. PMID: 40724971 Free PMC article. Review.
-
Nasopharyngeal carcinoma detected noninvasively in the real world using three gene methylation analyses from automatically processed bilateral nasal swab samples.BMC Cancer. 2025 Jul 5;25(1):1147. doi: 10.1186/s12885-025-14508-y. BMC Cancer. 2025. PMID: 40618071 Free PMC article.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394‐424. - PubMed
-
- Lee AWM, Ng WT, Chan LLK, et al. Evolution of treatment for nasopharyngeal cancer—success and setback in the intensity‐modulated radiotherapy era. Radiother Oncol. 2014;110(3):377‐384. - PubMed
-
- Mutirangura A, Pornthanakasem W, Theamboonlers A, et al. Epstein‒Barr viral DNA in serum of patients with nasopharyngeal carcinoma. Clin Cancer Res. 1998;4(3):665‐669. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous